RGDXQ (Response Genetics) Short-Term Debt: $1.33 Mil (As of Dec. 2015)


What is Response Genetics Short-Term Debt?

Response Genetics RGDXQ -98.00% Short-Term Debt is $1.33 Mil as of Dec. 2015.

Response Genetics's Short-Term Debt for the quarter that ended in Dec. 2015 was $1.33 Mil.

Response Genetics's quarterly Short-Term Debt stayed the same from Dec. 2014 ($0.00 Mil) to Mar. 2015 ($0.00 Mil) but then increased from Mar. 2015 ($0.00 Mil) to Dec. 2015 ($1.33 Mil).

Response Genetics's annual Short-Term Debt stayed the same from Dec. 2013 ($0.00 Mil) to Dec. 2014 ($0.00 Mil) but then increased from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($1.33 Mil).

Response Genetics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Response Genetics Short-Term Debt Related Terms

Response Genetics Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Response Genetics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Genetics Short-Term Debt Chart

Response Genetics Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 1.00 0.00 0.00 1.33

Response Genetics Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Dec15
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.33
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $1.33 Mil mean?
Response Genetics (RGDXQ) has a Short-Term Debt of $1.33 Mil as of Dec. 2015.
Is Response Genetics' Short-Term Debt too high?
Response Genetics' current Short-Term Debt is $1.33 Mil.
How does Response Genetics' Short-Term Debt compare to PSID and GBSN?
Response Genetics' Short-Term Debt of $1.33 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Diagnostics & Research company?
A good Short-Term Debt depends on the Medical Diagnostics & Research industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Response Genetics's current Short-Term Debt is $1.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Response Genetics stock overvalued right now?
Response Genetics (RGDXQ) has a current Short-Term Debt of $1.33 Mil. The current Short-Term Debt is $1.33 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Response Genetics (RGDXQ), the current Short-Term Debt is $1.33 Mil as of Dec. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Response Genetics Business Description

Address 201 Route 17 North, 2nd Floor, Rutherford, NJ, USA, 07070
Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.